Villarroya Francesc, Gavaldà-Navarro Aleix, Peyrou Marion, Villarroya Joan, Giralt Marta
Departament de Bioquímica i Biomedicina Molecular, Institut de Biomedicina, Universitat de Barcelona, Barcelona, Catalonia, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Barcelona, Spain.
Handb Exp Pharmacol. 2019;251:239-256. doi: 10.1007/164_2018_119.
Brown adipokines are regulatory factors secreted by brown and beige adipocytes that exhibit endocrine, paracrine, and autocrine actions. Peptidic and non-peptidic molecules, including miRNAs and lipids, are constituents of brown adipokines. Brown adipose tissue remodeling to meet thermogenic needs is dependent on the secretory properties of brown/beige adipocytes. The association between brown fat activity and a healthy metabolic profile, in relation to energy balance and glucose and lipid homeostasis, is influenced by the endocrine actions of brown adipokines. A comprehensive knowledge of the brown adipocyte secretome is still lacking. Advancements in the identification and characterization of brown adipokines will facilitate therapeutic interventions for metabolic diseases, as these molecules are obvious candidates to therapeutic agents. Moreover, identification of brown adipokines as circulating biomarkers of brown adipose tissue activity may be particularly useful for noninvasive assessment of brown adipose tissue alterations in human pathologies.
棕色脂肪因子是由棕色和米色脂肪细胞分泌的调节因子,具有内分泌、旁分泌和自分泌作用。肽类和非肽类分子,包括微小RNA和脂质,都是棕色脂肪因子的组成成分。棕色脂肪组织为满足产热需求而进行的重塑依赖于棕色/米色脂肪细胞的分泌特性。棕色脂肪活性与健康代谢状况之间的关联,涉及能量平衡以及葡萄糖和脂质稳态,受到棕色脂肪因子内分泌作用的影响。目前仍缺乏对棕色脂肪细胞分泌组的全面了解。棕色脂肪因子鉴定和表征方面的进展将有助于代谢疾病的治疗干预,因为这些分子显然是治疗药物的候选对象。此外,将棕色脂肪因子鉴定为棕色脂肪组织活性的循环生物标志物,可能对非侵入性评估人类疾病中棕色脂肪组织的改变特别有用。